We are live on ! Find out more

Healthcare
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
NVST icon
176
Envista
NVST
$4.55B
$4.55B $27.96 2.16%
CELC icon
177
Celcuity
CELC
$4.51B
$4.51B $92.49 5.44%
MANE
178
Veradermics Inc
MANE
$4.48B
$4.48B $107.28 5.29%
PBLS
179
Parabilis Medicines Inc
PBLS
$4.39B
$4.39B $35.90 5.71%
ELVN icon
180
Enliven Therapeutics
ELVN
$4.37B
$4.37B $61.11 5.29%
INDV icon
181
Indivior Pharmaceuticals
INDV
$4.31B
$4.31B $36.50 2.33%
ICUI icon
182
ICU Medical
ICUI
$4.3B
$4.3B $171.96 0.57%
RLAY icon
183
Relay Therapeutics
RLAY
$4.26B
$4.26B $19.54 4.05%
ITGR icon
184
Integer Holdings
ITGR
$4.25B
$4.25B $125.05 0.48%
IRTC icon
185
iRhythm Holdings
IRTC
$4.18B
$4.18B $127.13 1.98%
DOCS icon
186
Doximity
DOCS
$3.99B
$3.99B $21.89 1.06%
CON
187
Concentra Group Holdings
CON
$3.98B
$3.98B $31.12 1.83%
LFST icon
188
Lifestance Health
LFST
$3.92B
$3.92B $10.26 2.66%
ADPT icon
189
Adaptive Biotechnologies
ADPT
$3.9B
$3.9B $24.55 6.23%
HAE icon
190
Haemonetics
HAE
$3.88B
$3.88B $85.38 1.62%
VKTX icon
191
Viking Therapeutics
VKTX
$3.84B
$3.84B $32.94 1.01%
DNLI icon
192
Denali Therapeutics
DNLI
$3.84B
$3.84B $24.17 4.41%
VCYT icon
193
Veracyte
VCYT
$3.73B
$3.73B $46.41 3.48%
LEGN icon
194
Legend Biotech
LEGN
$3.7B
$3.7B $19.13 0.63%
WRBY icon
195
Warby Parker
WRBY
$3.67B
$3.67B $29.92 5.8%
RCUS icon
196
Arcus Biosciences
RCUS
$3.62B
$3.62B $28.80 4.27%
OGN icon
197
Organon & Co
OGN
$3.56B
$3.56B $13.56 0%
OPCH icon
198
Option Care Health
OPCH
$3.55B
$3.55B $23.69 0.04%
GPCR icon
199
Structure Therapeutics
GPCR
$3.53B
$3.53B $49.64 2.65%
TLX
200
Telix Pharmaceuticals
TLX
$3.49B
$3.49B $10.29 2.69%

Healthcare Stocks at a Glance

Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.

There are 1,066 Healthcare sector stocks tracked by Wall St. Rank, worth a combined $8.94T.

The largest by market cap are Eli Lilly (LLY) at $995B, Johnson & Johnson (JNJ) at $614B and AbbVie (ABBV) at $431B.

Among institutional investors, Waters Corp (WAT) drew the most net new fund positions in Q1 2026: 461 funds opened new positions, taking total fund holders up 365 (45%) quarter-over-quarter.

  • Combined market cap: $8.94T across 1,066 stocks.
  • Largest constituent: Eli Lilly (LLY), $995B market cap.
  • Most net new fund positions in Q1 2026: Waters Corp (WAT), +365 holders.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.